Form4insider filings, from the source

Company · CIK 0002023658 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Bicara Therapeutics Inc. · BCAX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $3.5M · 7net −$3.5M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesJul 7Jul 17Jul 28Aug 8Aug 18Aug 29Sep 9

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 8, 2026 SForm 4 →Sep 10, 4:23 pm EDTRyan CohlheppPresident, COO & Interim CEO, Director17,500$22.90$400,716181,641−8.79%10b5-1
Sep 8, 2026 MForm 4 →Sep 10, 4:23 pm EDTRyan CohlheppPresident, COO & Interim CEO, Director17,500$3.79$66,322199,141—10b5-1
Aug 10, 2026 SForm 4 →Aug 12, 4:19 pm EDTIvan HyepChief Financial Officer12,500$27.97$349,591129,855−8.78%10b5-1
Aug 10, 2026 MForm 4 →Aug 12, 4:19 pm EDTIvan HyepChief Financial Officer12,500$3.79$47,373142,355—10b5-1
Aug 10, 2026 SForm 4 →Aug 12, 4:19 pm EDTClaire MazumdarChief Executive Officer, Director10,000$27.98$279,750362,152−2.69%10b5-1
Aug 10, 2026 MForm 4 →Aug 12, 4:19 pm EDTClaire MazumdarChief Executive Officer, Director10,000$3.79$37,898372,152—10b5-1
Aug 10, 2026 SForm 4 →Aug 12, 4:19 pm EDTRyan CohlheppPresident and COO, Director18,750$27.98$524,533181,641−9.36%10b5-1
Aug 10, 2026 MForm 4 →Aug 12, 4:19 pm EDTRyan CohlheppPresident and COO, Director18,750$3.79$71,059200,391—10b5-1
Jul 10, 2026 SForm 4 →Jul 14, 4:22 pm EDTClaire MazumdarChief Executive Officer, Director10,000$28.42$284,198362,152−2.69%10b5-1
Jul 10, 2026 MForm 4 →Jul 14, 4:22 pm EDTClaire MazumdarChief Executive Officer, Director10,000$3.79$37,898372,152—10b5-1
Jul 8, 2026 SForm 4 →Jul 10, 4:10 pm EDTRyan CohlheppPresident and COO, Director28,750$28.98$833,129181,641−13.7%10b5-1
Jul 8, 2026 MForm 4 →Jul 10, 4:10 pm EDTRyan CohlheppPresident and COO, Director18,750$3.79$71,059210,391—10b5-1
Jul 8, 2026 SForm 4 →Jul 10, 4:10 pm EDTIvan HyepChief Financial Officer28,000$28.85$807,672129,855−17.7%10b5-1
Jul 8, 2026 MForm 4 →Jul 10, 4:10 pm EDTIvan HyepChief Financial Officer12,500$3.79$47,373157,855—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 8, 2026 MForm 4 →Sep 10, 4:23 pm EDTRyan CohlheppPresident, COO & Interim CEO, Director17,500——34,252—10b5-1
Aug 12, 2026 AForm 4 →Aug 14, 4:54 pm EDTJennifer LarsonChief Financial Officer285,000——285,000—
Aug 10, 2026 MForm 4 →Aug 12, 4:19 pm EDTIvan HyepChief Financial Officer12,500——26,336—10b5-1
Aug 10, 2026 MForm 4 →Aug 12, 4:19 pm EDTClaire MazumdarChief Executive Officer, Director10,000——110,546—10b5-1
Aug 10, 2026 MForm 4 →Aug 12, 4:19 pm EDTRyan CohlheppPresident and COO, Director18,750——51,752—10b5-1
Jul 28, 2026 AForm 4 →Jul 29, 4:18 pm EDTJeremy BenderDirector38,950——38,950—
Jul 28, 2026 AForm 4 →Jul 29, 4:18 pm EDTChristy J. OligerDirector38,950——38,950—
Jul 10, 2026 MForm 4 →Jul 14, 4:22 pm EDTClaire MazumdarChief Executive Officer, Director10,000——120,546—10b5-1
Jul 8, 2026 MForm 4 →Jul 10, 4:10 pm EDTRyan CohlheppPresident and COO, Director18,750——70,502—10b5-1
Jul 8, 2026 MForm 4 →Jul 10, 4:10 pm EDTIvan HyepChief Financial Officer12,500——38,836—10b5-1
Jun 9, 2026 AForm 4 →Jun 10, 4:43 pm EDTRA CAPITAL MANAGEMENT, L.P. +4Director, 10% Owner19,475——19,475—
Jun 9, 2026 AForm 4 →Jun 10, 4:35 pm EDTChristopher BowdenDirector19,475——19,475—
Jun 9, 2026 AForm 4 →Jun 10, 4:34 pm EDTKate HavilandDirector19,475——19,475—
Jun 9, 2026 AForm 4 →Jun 10, 4:34 pm EDTKiran Mazumdar-ShawDirector19,475——19,475—
Jun 9, 2026 AForm 4 →Jun 10, 4:33 pm EDTScott M. RobertsonDirector19,475——19,475—
Jun 9, 2026 AForm 4 →Jun 10, 4:33 pm EDTMichael PowellDirector19,475——19,475—
Jun 9, 2026 AForm 4 →Jun 10, 4:32 pm EDTJake SimsonDirector19,475——19,475—